{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:30:38Z","timestamp":1761129038043},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.biologicals.2012.10.003","type":"journal-article","created":{"date-parts":[[2012,11,10]],"date-time":"2012-11-10T21:15:17Z","timestamp":1352582117000},"page":"88-92","source":"Crossref","is-referenced-by-count":6,"title":["Analyzing titers of antibodies against bacterial and viral antigens, and bacterial toxoids in the intravenous immunoglobulins utilized in Taiwan"],"prefix":"10.1016","volume":"41","author":[{"given":"Chi-Yu","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiu-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Teng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Yang-Chih Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Fang","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Der-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2012.10.003_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.molimm.2004.07.046","article-title":"Therapeutic intravenous immunoglobulins","volume":"42","author":"Lemieux","year":"2005","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.biologicals.2012.10.003_bib2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","article-title":"An overview of the immune system","volume":"357","author":"Parkin","year":"2001","journal-title":"The Lancet"},{"key":"10.1016\/j.biologicals.2012.10.003_bib3","series-title":"Immunology: understanding the immune system","author":"Elgert","year":"2009"},{"key":"10.1016\/j.biologicals.2012.10.003_bib4","series-title":"British pharmacopoeia 2008","author":"British Pharmacopoeia Commission","year":"2007"},{"key":"10.1016\/j.biologicals.2012.10.003_bib5","series-title":"European pharmacopoeia 6.2","author":"Council of Europe","year":"2008"},{"key":"10.1016\/j.biologicals.2012.10.003_bib6","series-title":"United States pharmacopeia 32 national formulary 27","author":"The United States Pharmacopeial Convention","year":"2009"},{"key":"10.1016\/j.biologicals.2012.10.003_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1831","article-title":"Prescribing intravenous immunoglobulin: summary of department of health guidelines","volume":"337","author":"Provan","year":"2008","journal-title":"British Medical Journal"},{"key":"10.1016\/j.biologicals.2012.10.003_bib8","series-title":"Intravenous immune globulins (IVIG) side-by-side comparison","author":"American Society of Health-System Pharmacists","year":"2007"},{"key":"10.1016\/j.biologicals.2012.10.003_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S0100-879X2007000100009","article-title":"Determination of low tetanus or diphtheria antitoxin titers in sera by a toxin neutralization assay and a modified toxin-binding inhibition test","volume":"40","author":"Sonobe","year":"2007","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"10.1016\/j.biologicals.2012.10.003_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/506363","article-title":"Measles-virus-neutralizing antibodies in intravenous immunoglobulins","volume":"194","author":"Audet","year":"2006","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.biologicals.2012.10.003_bib11","article-title":"Pertussis vaccination: use of acellular pertussis vaccines among infants and young children \u2013 recommendations of the advisory committee on immunization practices (ACIP)","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.biologicals.2012.10.003_bib12","series-title":"Notes on vaccination","author":"Centers for Disease Control Taiwan","year":"2011"},{"key":"10.1016\/j.biologicals.2012.10.003_bib13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0022-3476(98)70395-6","article-title":"Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis","volume":"132","author":"Giuliano","year":"1998","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.biologicals.2012.10.003_bib14","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsa0806477","article-title":"Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases","volume":"360","author":"Omer","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.biologicals.2012.10.003_bib15","doi-asserted-by":"crossref","first-page":"e836","DOI":"10.1542\/peds.2007-1760","article-title":"Media coverage of the measles-mumps-rubella vaccine and autism controversy and its relationship to MMR immunization rates in the United States","volume":"121","author":"Smith","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.biologicals.2012.10.003_bib16","series-title":"The immunological basis for immunization series \u2013 module 7: measles","author":"Moss","year":"2009"},{"key":"10.1016\/j.biologicals.2012.10.003_bib17","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.23543","article-title":"Determination of immune memory to hepatitis B vaccination through early booster response in college students","volume":"51","author":"Jan","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.biologicals.2012.10.003_bib18","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/he.2000.6407","article-title":"Reactivity of 13 in\u00a0vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays","volume":"31","author":"Ireland","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.biologicals.2012.10.003_bib19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0168-8278(94)80015-4","article-title":"Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes","volume":"20","author":"Ackerman","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.biologicals.2012.10.003_bib20","series-title":"The immunological basis for immunization series \u2013 module 3: tetanus","author":"Borrow","year":"2006"},{"key":"10.1016\/j.biologicals.2012.10.003_bib21","series-title":"The immunological basis for immunization series \u2013 module 2: diphtheria","author":"Scheifele","year":"2009"},{"key":"10.1016\/j.biologicals.2012.10.003_bib22","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1067\/mpd.2001.113710","article-title":"Current efficacy of postexposure prophylaxis against measles with immunoglobulin","volume":"138","author":"Endo","year":"2001","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.biologicals.2012.10.003_bib23","author":"Centers for Disease Control Taiwan"},{"key":"10.1016\/j.biologicals.2012.10.003_bib24","series-title":"Vaccines & immunizations","author":"Centers for Disease Control and Prevention","year":"2012"},{"key":"10.1016\/j.biologicals.2012.10.003_bib25","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.vaccine.2010.12.032","article-title":"The changing epidemiology of varicella incidence after implementation of the one-dose varicella vaccination policy","volume":"29","author":"Lian","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2012.10.003_bib26","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992\u20132002","volume":"191","author":"Jumaan","year":"2005","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.biologicals.2012.10.003_bib27","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2012.10.003_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/clinids\/5.3.463","article-title":"Herd immunity and measles","volume":"5","author":"Fox","year":"1983","journal-title":"Review of Infectious Diseases"},{"key":"10.1016\/j.biologicals.2012.10.003_bib29","series-title":"Health, United States","author":"National Center for Health Statistics","year":"2011"},{"key":"10.1016\/j.biologicals.2012.10.003_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jaci.2009.09.008","article-title":"Hepatitis A virus antibodies in immunoglobulin preparations","volume":"125","author":"Farcet","year":"2010","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.biologicals.2012.10.003_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jaci.2007.11.001","article-title":"Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations","volume":"121","author":"Lejtenyi","year":"2008","journal-title":"The Journal of Allergy and Clinical Immunology"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510561200173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510561200173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T09:27:14Z","timestamp":1540114034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104510561200173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S104510561200173X"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2012.10.003","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}